title: Long-Acting Opioids for Treating Neonatal Abstinence Syndrome: A High Price for a Short Stay?
authors.affiliation: Department of Anesthesia, Stanford University School of Medicine, Stanford, California.
authors.forename: Gary
authors.initials: G
authors.lastname: Peltz
authors.affiliation: Department of Pediatrics and Anesthesia, Stanford University School of Medicine, Stanford, California.
authors.forename: Kanwaljeet J S
authors.initials: KJ
authors.lastname: Anand
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D007231:Infant, Newborn; D007902:Length of Stay / Q000191:economics; D008691:Methadone / Q000627:therapeutic use*; D009020:Morphine / Q000627:therapeutic use; D009357:Neonatal Abstinence Syndrome / Q000188:drug therapy*; D017294:Ondansetron / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000627:therapeutic use
chemical_list: D000701:Analgesics, Opioid; D012702:Serotonin Antagonists; D017294:Ondansetron; D009020:Morphine; D008691:Methadone